These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19539541)

  • 1. Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy.
    Christiaans I; Lekanne dit Deprez RH; van Langen IM; Wilde AA
    Heart Rhythm; 2009 Sep; 6(9):1366-9. PubMed ID: 19539541
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.
    Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertrophic cardiomyopathy, sudden death, and implantable cardiac defibrillators: how low the bar?
    Nishimura RA; Ommen SR
    JAMA; 2007 Jul; 298(4):452-4. PubMed ID: 17652299
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study.
    Penicka M; Gregor P; Kerekes R; Marek D; Curila K; Krupicka J;
    J Mol Diagn; 2009 Jan; 11(1):35-41. PubMed ID: 19074594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Genetic Basis of Hypertrophic Cardiomyopathy.
    Marian AJ
    Circ Res; 2021 May; 128(10):1533-1553. PubMed ID: 33983830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aborted sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Casey SA; Almquist AK
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):263. PubMed ID: 10090231
    [No Abstract]   [Full Text] [Related]  

  • 7. Genes frequently associated with sudden death in primary hypertrophic cardiomyopathy.
    Herrera-Rodríguez DL; Totomoch-Serra A; Rosas-Madrigal S; Luna-Limón C; Marroquín-Ramírez D; Carnevale A; Rosendo-Gutiérrez R; Villarreal-Molina MT; Márquez-Murillo MF
    Arch Cardiol Mex; 2020; 90(1):58-68. PubMed ID: 31996869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel MYH7 mutation in a family with cardiomyopathy presenting with restrictive physiology and varying degrees of left ventricle hypertrophy.
    Yu BL; Xiang R; Hu D; Peng DQ
    Eur Heart J; 2015 Jan; 36(3):178. PubMed ID: 25422285
    [No Abstract]   [Full Text] [Related]  

  • 9. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
    Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lethal pedigree of hypertrophic cardiomyopathy associated with mild left ventricular hypertrophy.
    Watson P; Burstow D; Stafford W
    Aust N Z J Med; 1996 Dec; 26(6):845-6. PubMed ID: 9028521
    [No Abstract]   [Full Text] [Related]  

  • 12. The Cumulative Effects of the MYH7-V878A and CACNA1C-A1594V Mutations in a Chinese Family with Hypertrophic Cardiomyopathy.
    Wang B; Guo RQ; Wang J; Yang F; Zuo L; Liu Y; Shao H; Ju Y; Sun C; Xu L; Zhang YM; Wang LF; Liu LW
    Cardiology; 2017; 138(4):228-237. PubMed ID: 28866666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sudden death and ventricular fibrillation of possible ischemic origin in a boy with hypertrophic myocardiopathy].
    Gutiérrez Díez A; Tamariz-Martel Moreno A; Baño Rodrigo A; Serrano González A
    Rev Esp Cardiol; 2000 Feb; 53(2):290-3. PubMed ID: 10734761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy.
    Furushima H; Chinushi M; Iijima K; Sanada A; Izumi D; Hosaka Y; Aizawa Y
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):991-9. PubMed ID: 20487113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations of beta-MYH7 in Venezuelan patients with hypertrophic cardiomyopathy.
    Rodríguez R; Guerrero D; Rivas Y; Lacruz A; Flores Y
    Invest Clin; 2014 Mar; 55(1):23-31. PubMed ID: 24758099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation-specific pathology and treatment of hypertrophic cardiomyopathy in patients, mouse models and human engineered heart tissue.
    Wijnker PJM; van der Velden J
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165774. PubMed ID: 32217077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-shock oversensing by a subcutaneous defibrillator resulting in inappropriate withholding of post-shock bradycardia pacing.
    Maass AH; Van Gelder IC
    Europace; 2014 Jul; 16(7):1032. PubMed ID: 24792457
    [No Abstract]   [Full Text] [Related]  

  • 19. A Long Term Follow-up Study of Carriers of Hypertrophic Cardiomyopathy Mutations.
    McTaggart DR; Ogden KJ; Marathe JA
    Heart Lung Circ; 2017 Jan; 26(1):18-24. PubMed ID: 27373729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.